NASDAQ: BWAY

Brainsway is a leader in non-invasive treatments for brain disorders utilizing Deep Transcranial Magnetic Stimulation (Deep TMS). Brainsway’s unique patented technology was developed in collaboration with the National Institute of Health and is FDA and CE cleared to treat clinical depression and obsessive-compulsive disorder (OCD) in adults.